Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Amedisys Q1 2024 Adj EPS $1.03 Beats $1.02 Estimate, Sales $571.400M Beat $565.380M Estimate

Author: Benzinga Newsdesk | April 24, 2024 04:47pm
Amedisys (NASDAQ:AMED) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $1.02 by 0.98 percent. The company reported quarterly sales of $571.400 million which beat the analyst consensus estimate of $565.380 million by 1.06 percent. This is a 2.70 percent increase over sales of $556.389 million the same period last year.

Posted In: AMED


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist